Biomarkers in Early DevelopmentWednesday, 18 May 2011 at 17:00  Add to Calendar ▼2011-05-18 17:00:002011-05-18 18:00:00Europe/LondonBiomarkers in Early DevelopmentTheranostics for Personalized Medicine in LondonLondonSELECTBIOenquiries@selectbiosciences.comIn early development, two types of biomarkers are important: - Pharmacodynamic markers to assess compound activity in humans (phase I) and to provide quantitative data supporting Phase II transition and dose selection. - Predictive markers to assess identification of patient populations that receive a high level of clinical benefit. For these, the development of robust assays early on is critical. |
Add to Calendar ▼2011-05-18 00:00:002011-05-19 00:00:00Europe/LondonTheranostics for Personalized MedicineTheranostics for Personalized Medicine in LondonLondonSELECTBIOenquiries@selectbiosciences.com
